Home › Occupations › Molecular and Cellular Biologists › Phoenix, AZ
Molecular and Cellular Biologists in Phoenix, AZ: H-1B salaries
42 labor condition applications for this occupation with a work site in Phoenix, AZ. Median offered base salary $70,000; middle half $61,516–$103,624.
By wage level
| Wage level | Median salary |
|---|---|
| Level I (entry) | $66,082 |
| Level II (qualified) | $69,368 |
| Level III (experienced) | $109,373 |
| Level IV (fully competent) | $133,000 |
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Employers
| Employer | LCAs | Median salary |
|---|---|---|
| The Translational Genomics Research Institute | 18 | $66,296 |
| The University of Arizona | 7 | $70,000 |
| National Institutes of Health, HHS | 2 | $98,476 |
| Ambry Genetics Corporation | 2 | $111,005 |
| Phoenix Children's Hospital | 2 | $88,670 |
| Exact Sciences Corporation | 2 | $122,577 |
| Dignity Health | 2 | $68,567 |
| DREAM Venture Labs Inc. | 2 | — |
| Recognition Analytix, Inc. | 1 | $87,339 |
| Mayo Clinic | 1 | $62,795 |
| Banner Health | 1 | $91,957 |
| Astrix Technology, LLC | 1 | — |
| Cedars-Sinai Medical Center | 1 | $104,249 |
Job titles
- Post Doctoral Fellow6
- Staff Scientist4
- Bioinformatics Scientist3
- Assistant Research Professor3
- Bioinformatician3
- Research Fellow2
- Researcher/Scientist III2
- Computational Scientist2
- Bioinformatics Engineer II2
- Assistant Professor2
- Molecular Biology Fellow2
- Research Scientist1
- Variant Assessment Scientist I1
- Postdoctoral Research Associate III1
- Postdoctoral Research Associate IV1
H-1B sponsors in Phoenix, AZ →
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).